Establishment Labs Holdings Inc.

Stage 4 · Declining · week 3

As of Oct 22, 2026, Establishment Labs Holdings is in Stage 4, the downtrend phase, now in week 3 (since Oct 8, 2026). It closed at $63.52, 33.6% below its 52-week high and below its 200-day average, which is falling.

$63.52

+1.99% today

$1.9B · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ESTA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 23w

S3 14w

S2 21w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 23w → S1 10w → S2 10w → S3 14w → S4 5w → S1 11w → S4 13w → S1 1w → S4 8w → S1 3w → S2 8w → S3 5w → S2 21w → S3 11w → S2 13w → S3 5w → S4 2w current

Total tracked: 165 weeks across 17 stage runs.

ESTA among Medical Devices29th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…29	ESTAEstablishment Labs Holdings Inc.	Stage 4 · wk 3	76	−6.3%

vs 52W High

-33.6%

$47.80 lo$95.65 hi

33.6% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 3

1w13w26w

Week 3, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-12.3%

200 DMA: $72.45 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

2.03x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-6.3%

-31.2%

-2.5%

YTD

-7.7%

+28.8%

Scan Membership

Breakout Watch

Latest: 2024-04-08

7 appearances in last 60 days. First seen: 2019-12-26.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 3 · Vol 2.03x

2026-10-21S4

Wk 2 · Vol 1.07x

2026-10-20S4

Wk 2 · Vol 0.93x

2026-10-19S4

Wk 2 · Vol 0.87x

2026-10-16S4

Wk 2 · Vol 0.71x

2026-10-15S4

Wk 2 · Vol 1.15x

2026-10-14S4

Wk 1 · Vol 1.19x

2026-10-13S4

Wk 1 · Vol 1.13x

2026-10-12S4

Wk 1 · Vol 0.65x

2026-10-09S4

Wk 1 · Vol 0.70x

2026-10-08S43→4

Wk 1 · Vol 1.30x

2026-10-07S3

Wk 6 · Vol 1.02x

Moving averages & range

50 DMA

$68.21

200 DMA

$72.45

52W High

$95.65

52W Low

$47.80

5D Low

$58.26

Resistance levels (recent highs)

20d High

$66.47

60d High

$94.61

120d High

$95.65

250d High

$95.65

Next resistance

+4.6%

to 20d High

ROE

-175.3%

Profit margin -15.8%

Dividend Yield

0.00%

P/B 87.6

Establishment Labs Holdings: quick answers

What stage is Establishment Labs Holdings in?

As of Oct 22, 2026, Establishment Labs Holdings (ESTA) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 8, 2026 and is in week 3. What the four stages mean

Is Establishment Labs Holdings in an uptrend?

No. Establishment Labs Holdings is in a Stage 4 downtrend. It trades 12.3% below its 200-day average, which is falling.

How far is Establishment Labs Holdings from its 52-week high?

Establishment Labs Holdings closed at $63.52 on Oct 22, 2026, 33.6% below its 52-week high of $95.65. Its 52-week low is $47.80.

How has Establishment Labs Holdings performed over the past year?

As of Oct 22, 2026, Establishment Labs Holdings is up 28.8% over the past year and down 7.7% so far in 2026.

Which sector and industry is Establishment Labs Holdings in?

Establishment Labs Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.